Meanwhile, it has been well documented that tumor suppressor p53 is frequently mutated in pancreatic cancer tissues (around 75%) [50], indicating that mutant p53 contributes to the development of GEM-resistant nature of pancreatic cancer. This evidence concerns the gene TP53 and familial pancreatic carcinoma.